Abilify

Aripiprazole (Abilify, Abilify Discmelt) is an atypical antipsychotic and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. It was approved by the Food and Drug Administration (FDA) for schizophrenia on November 15, 2002, for acute manic and mixed episodes associated with bipolar disorder on October 1, 2004, and as an adjunct for major depressive disorder on November 20, 2007. Aripiprazole was developed by Otsuka in Japan, and in the United States, Otsuka America markets it jointly with Bristol-Myers Squibb.

Reference: Wikipedia

Keep in mind that if you take Abilify, that medicines are not covered by your Medicare Supplement, but by your Part D, Prescription Drug coverage.

If you have limited income, you may qualify for “extra help” with the cost of your prescription medications. You can get more information and apply Here.

* The information on this page is for reference only. Always seek the advice of your physician before taking any prescription medication.